Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2025 Jun 19;33(8):4008. doi: 10.1016/j.ymthe.2025.06.030

Retraction Notice to: LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis

Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang ∗
PMCID: PMC12461646  PMID: 40541189

Main text

(Molecular Therapy 25, 2383–2393; October 2017)

This article has been retracted at the request of the the editor-in-chief. A reader communicated concerns to the editorial office. These concerns are also echoed in a Pubpeer thread (https://pubpeer.com/publications/D9519B92998E6AD186E49846F789C4) where readers drew attention to similarities between figures within this article. Image analysis performed by the editorial office revealed evidence of image duplication within Figures 2D, 2E, 4C, 6C, and 6D of this article. Evidence of image recycling was also found between images in Figures 3J, 4B, and 6B of this article and an article in Oncotarget by the same authors (Zhu et al., 2017, Oncotarget 8, 71881–71893, https://doi.org/10.18632/oncotarget.17985). This reuse of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors did not agree to retract.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES